Skip to main content

Language: English / Gàidhlig

Loading…

Seòmar agus comataidhean

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

  • Written questions must be answered within 10 working days (20 working days during recess)
  • Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search.  There is a SPICe fact sheet listing Urgent and emergency questions.

Find out more about parliamentary questions

Criathragan Hide all filters

Dates of parliamentary sessions
  1. Session 1: 12 May 1999 to 31 March 2003
  2. Session 2: 7 May 2003 to 2 April 2007
  3. Session 3: 9 May 2007 to 22 March 2011
  4. Session 4: 11 May 2011 to 23 March 2016
  5. Session 5: 12 May 2016 to 5 May 2021
  6. Current session: 12 May 2021 to 25 December 2024
Answer status
Question type

Displaying 1031 questions Show Answers

|

Question reference: S4W-06543

  • Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
  • Date lodged: Friday, 30 March 2012
  • Current Status: Answered by Nicola Sturgeon on 23 April 2012

To ask the Scottish Executive whether the multiple sclerosis drug, Fingolimod, is (a) approved by the Scottish Medicines Consortium and (b) available in the NHS.

Question reference: S4W-06539

  • Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
  • Date lodged: Friday, 30 March 2012
  • Current Status: Answered by Nicola Sturgeon on 23 April 2012

To ask the Scottish Executive how many consultants are currently undergoing training in community sexual and reproductive health, broken down by (a) the year that the training commenced and (b) NHS board.

Question reference: S4W-06540

  • Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
  • Date lodged: Friday, 30 March 2012
  • Current Status: Answered by Nicola Sturgeon on 23 April 2012

To ask the Scottish Executive how many trained consultants there have been in community sexual and reproductive health in each of the last five years, broken down by NHS board.

Question reference: S4W-06538

  • Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
  • Date lodged: Friday, 30 March 2012
  • Current Status: Answered by Nicola Sturgeon on 23 April 2012

To ask the Scottish Executive how many training places in community sexual and reproductive health have been allocated to consultants in each of the last five years, broken down by NHS board.

Question reference: S4W-06398

  • Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
  • Date lodged: Thursday, 29 March 2012
  • Current Status: Answered by Nicola Sturgeon on 23 April 2012

To ask the Scottish Executive what discussions it has had with the UK Government on the implementation of value-based pricing of medicines.

Question reference: S4W-06392

  • Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
  • Date lodged: Thursday, 29 March 2012
  • Current Status: Answered by Nicola Sturgeon on 23 April 2012

To ask the Scottish Executive how many patients have been given access to cancer medicines that were approved by the Scottish Medicines Consortium under a patient access scheme since 2011, also broken down by (a) NHS board and (b) medicine.

Question reference: S4W-06400

  • Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
  • Date lodged: Thursday, 29 March 2012
  • Current Status: Answered by Nicola Sturgeon on 23 April 2012

To ask the Scottish Executive whether it will conduct a review of the impact of the guidance that was issued in March 2011 on individual patient treatment requests and, if so, when.

Question reference: S4W-06396

  • Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
  • Date lodged: Thursday, 29 March 2012
  • Current Status: Answered by Nicola Sturgeon on 23 April 2012

To ask the Scottish Executive what assessment it made of the suitability of the cost per quality-adjusted life year ration in evaluating treatments effective in small cohorts of poor prognosis patients when considering petition PE1108 on the availability on the NHS of cancer treatment drugs.

Question reference: S4W-06399

  • Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
  • Date lodged: Thursday, 29 March 2012
  • Current Status: Answered by Nicola Sturgeon on 23 April 2012

To ask the Scottish Executive when it will publish further guidance on management of formulary arrangements by NHS boards.

Question reference: S4W-06397

  • Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
  • Date lodged: Thursday, 29 March 2012
  • Current Status: Answered by Nicola Sturgeon on 23 April 2012

To ask the Scottish Executive what steps it will take to ensure that patients with a cancer that has spread will receive equitable access to the same medicines as patients in England.